title: Serum sulfhydryl levels in rheumatoid patients treated with haloperidol.
abstract: Six months of haloperidol treatment significantly increased the serum sulfhydryl (SH) levels in all 12 rheumatoid arthritis (RA) patients studied and significantly decreased the PIP joints technetium index (Tc-index), erythrocyte sedimentation rate (ESR) and joint count. These findings suggest a specific antirheumatic activity of haloperidol in the RA patients.
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001799:Blood Sedimentation; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D012701:Serotonin / Q000097:blood; D013438:Sulfhydryl Compounds / Q000097:blood*; D013667:Technetium
chemical_list: D013438:Sulfhydryl Compounds; D012701:Serotonin; D013667:Technetium; D006220:Haloperidol